Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia. - Wikidata - wikimedia - TriplyDB

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

http://www.wikidata.org/entity/Q36070567

about

Genetic abnormalities associated with acute lymphoblastic leukemia Oncogenic kinase fusions: an evolving arena with innovative clinical opportunities Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.Deep Profiling of Proteome and Phosphoproteome by Isobaric Labeling, Extensive Liquid Chromatography, and Mass Spectrometry.Extensive Peptide Fractionation and y1 Ion-Based Interference Detection Method for Enabling Accurate Quantification by Isobaric Labeling and Mass Spectrometry.Synergism of FAK and tyrosine kinase inhibition in Ph+ B-ALL.Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia.Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance.Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL.Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review.Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.Ph-like acute lymphoblastic leukemia.TP53 Mutations in Hypodiploid Acute Lymphoblastic Leukemia.Philadelphia-Like Acute Lymphoblastic Leukemia in Adults.The making of a lymphocyte: the choice among disparate cell fates and the IKAROS enigma.Transcriptional circuits in B cell transformation.Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.Philadelphia chromosome-like acute lymphoblastic leukemia.Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification.Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia.Retinoic acid, CYP26, and drug resistance in the stem cell niche.Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients.Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes.

P2860

Q26753823-9C8D2A1B-146C-499C-AB1F-D3C3B63C05D2 Q26768158-0A4C41B7-1B0B-4233-926B-B48C115BE929 Q33573735-989AA1A9-A258-4021-8C18-0C7B6E55DE83 Q33578333-BBBF00A7-1205-4738-9F25-FC56A4283F23 Q33719518-267E02F2-1790-4D69-AEFB-73A877B705C4 Q33787283-DE5C7099-22CD-4E0A-A152-4D6B598480C4 Q36833021-472BD315-529E-4194-B312-23C5DDEF4570 Q37343021-61610090-D27F-48B2-AC24-1FD06F32E10F Q37452148-226D83C8-84F7-42E2-91FD-D8EB435EB0A4 Q37483972-C3A6178A-1D3F-492E-8CD7-F9870B44F75A Q38716760-461BBEDB-04FE-4155-8783-3CAE478DF949 Q38716763-D7F8A1D9-91A1-49F7-961E-F1437C3B60C8 Q38874309-BF79E1B2-CB58-4AF6-80BE-36E742AFA43B Q39014321-CD693800-0E37-4FDC-AF67-FFA164503427 Q39027852-34FEEA2A-2DB4-4DC5-AE52-567DBE9CC6EE Q39047607-5CEDFF43-D216-47EC-B45B-204623EDAB86 Q39210250-31D3485F-20B1-4A6D-90F2-838AFFFB7363 Q39225226-B5857B11-A27B-456D-B7AC-360D43DDC3B6 Q39278378-C1D73ABD-E2A0-4B41-A42A-154E4E458909 Q39985910-65BAFE28-0BE2-4EFC-A402-59E1B1F10A50 Q41000106-9A0BA7E8-0A0B-43AF-A1A1-3DC56C1C1334 Q42361915-FEB77CAE-870D-45E5-9EEC-F036FAF9CE75 Q43431904-19CF1E05-F757-4599-9FEE-B895C091DC43 Q47109080-369823AC-DBF3-480F-9A9B-B5644F07CD0C Q47234913-AB42BB67-6C11-46F2-9670-3CC5EFC3895F Q47858676-778E47AF-9FDD-4E20-80CC-ED0C44AE00FE Q48015915-FCEC2E01-E50A-4AF7-BA3E-672F96D6F730 Q50038847-56ABF74F-4F28-44A9-B285-98831CA4016E Q51343198-74450214-62A4-43C9-9F13-BD16DA3159EC Q52717677-250FA3F3-8136-4A4B-A6D9-9CB86B56D420 Q52763617-30F38526-AD1A-448E-871B-F649F4300479 Q53703572-70744509-CBC2-47C6-9BA8-05E60192BB1B Q54989161-89C89B9E-AF15-4B08-9A0D-D34AD01B47C8 Q55387154-F149A79A-4142-4901-AB23-762284866F21

P2860

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

http://www.wikidata.org/entity/Q36070567

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

@ast

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

@en

type

label

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

@ast

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

@en

prefLabel

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

@ast

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

@en

P1433

Q36070567-C41A3518-AD35-4615-A9AB-7D539A828C87

P1476

Q36070567-31A641F5-BBFA-4398-B479-EE34BD916718

P2093

Q36070567-04A29FBE-6245-4705-A6F9-324F05A99667

Q36070567-075C438C-C1E4-4B91-B415-FF70C7A5D21C

Q36070567-147CD7A8-3EF0-4FF6-9924-18DA0E665DF5

Q36070567-18AC619B-1928-4971-A470-9A9E550756E3

Q36070567-1993C1B1-6570-4010-8729-8AFBD451B384

Q36070567-22692348-7B20-406E-84E6-F35F78FA7C38

Q36070567-23FFA713-2E8E-4D8D-A0A4-4A54F26756C5

Q36070567-26CD11ED-FC28-43FD-BA6D-BB404AD4F78F

Q36070567-3084B6BF-85CA-4D7A-820D-637B9AECEB34

Q36070567-39F3CA28-2729-4F01-88C9-F771CDF968F9

P2860

Q36070567-037F3C78-E251-4D54-A0E5-D96784D289DA

Q36070567-065CFC33-6DF3-48D5-8F23-487F84D8A819

Q36070567-07E9263D-8E75-4B7D-BEC5-19B7E8212D74

Q36070567-08DB8F12-F782-4EB3-95BC-690437743584

Q36070567-10222775-2BF1-4F64-AB3D-96D21C403DF2

Q36070567-139D18A7-ED62-4C69-9F43-E1045C14D20B

Q36070567-15C6B8F5-D905-40C9-88CA-2E9607260495

Q36070567-1742C4A2-6BA3-4767-BDBA-20EBC1A94A43

Q36070567-17AE0330-D88D-42A6-88C2-E5C82E411590

Q36070567-1CC8CF4C-A941-407D-AB37-27BBBDC0B87B

P304

Q36070567-CDF2779C-16AB-4A99-B0A8-5014799D3D7D

P31

Q36070567-04064961-5C4A-4F01-9423-9CB30EB5E5CE

P356

Q36070567-F31D785E-2A28-47AB-912F-1749E4146614

P433

Q36070567-C8908E06-C023-4E16-A939-3684642A1AD3

P478

Q36070567-31257493-34E6-4398-89E3-86D5E7B48CF9

P50

Q36070567-449F9AFC-C2E6-48D3-B940-B83AC149CEE4

Q36070567-5E488197-7015-44A5-80F3-C87F03579ADB

Q36070567-70B636FE-350C-48ED-9CD7-27A77B39CD4E

Q36070567-A40F1663-CE80-423D-A304-0376BEF39F5C

Q36070567-A5E8D3ED-8502-43A1-A99D-66B9EA72DBCD

Q36070567-AA9DC456-C49A-453E-BCDD-94FF021D5CBC

Q36070567-EA1E0554-B9F7-493D-8235-B7DD3883AF3B

Q36070567-FA910518-D919-4500-92B6-B6AB58BE52E5

P577

Q36070567-8B5D3D52-3E47-4C76-8E6D-BC1A5B3F5D11

P5875

Q36070567-7E221977-6A54-4D44-BA52-C45961AE50E2

P698

Q36070567-896B2A4B-CD77-4701-ABC5-5EAB5EEEE40E

P921

Q36070567-8B550798-C7D6-431F-859A-58D7144876F9

P932

Q36070567-856710B0-3B61-4671-97C8-7CCDC272895B

P356

J.CCELL.2015.07.016

P1433

P1476

Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia.

@en

P2093

Anand Mayasundari

http://www.w3.org/2001/XMLSchema#string

Burgess Freeman

http://www.w3.org/2001/XMLSchema#string

Cheryl L Willman

http://www.w3.org/2001/XMLSchema#string

Chunxu Qu

http://www.w3.org/2001/XMLSchema#string

Dan McGoldrick

http://www.w3.org/2001/XMLSchema#string

Debbie Payne-Turner

http://www.w3.org/2001/XMLSchema#string

Elisabeth M Paietta

http://www.w3.org/2001/XMLSchema#string

Faiyaz Notta

http://www.w3.org/2001/XMLSchema#string

Guangchun Song

http://www.w3.org/2001/XMLSchema#string

Jacob Rowe

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Acute lymphoblastic leukaemia

Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

Expression of Thy-1 on human hematopoietic progenitor cells

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.

The Ikaros gene is required for the development of all lymphoid lineages

P304

343-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCELL.2015.07.016

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Charles G. Mullighan

Kelly McCastlain

Ross A. Dickins

Sharyn D. Baker

William Caufield

Ilaria Iacobucci

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281483725

http://www.w3.org/2001/XMLSchema#string

P698

26321221

http://www.w3.org/2001/XMLSchema#string

P921

P932

4573904

http://www.w3.org/2001/XMLSchema#string